• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒毒素对遗传性痉挛性截瘫患者髋内收肌的功能影响及其后续拉伸。

Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia.

机构信息

Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, 6541GX Nijmegen, The Netherlands.

出版信息

J Rehabil Med. 2019 Jun 18;51(6):434-441. doi: 10.2340/16501977-2556.

DOI:10.2340/16501977-2556
PMID:30968942
Abstract

OBJECTIVE

To investigate the functional effects of bilateral botulinum toxin A treatment and subsequent stretching of spastic hip adductors on gait and reactive lateral stepping responses in patients with pure hereditary spastic paraplegia.

DESIGN

Explorative pre-post intervention study.

PATIENTS

Twenty-five patients with pure hereditary spastic paraplegia.

METHODS

Patients were treated with bilateral botulinum toxin A injections in the hip adductors and performed daily self-administered stretching exercises for 16 weeks. Before the intervention (T0), and 6 (T1) and 16 (T2) weeks thereafter, gait width, gait speed, and leg angles at first stepping-foot contact after lateral balance perturbations were assessed, as well as the corresponding success rates of reactive lateral steps.

RESULTS

Compared with baseline, gait width increased by 12.6% and 9.7% and comfortable gait speed by 8.3% and 11.5% at T1 and T2, respectively. In known perturbation directions, leg angles increased by 5.9% at T1 and 8.0% at T2, while success rates increased from 70% at baseline to 90% at T1 and T2. No effects were found for maximal gait speed or lateral stepping responses in unknown perturbation directions.

CONCLUSION

Bilateral botulinum toxin A treatment and subsequent stretching of the hip adductors may improve gait and reactive lateral stepping in patients with pure hereditary spastic paraplegia.

摘要

目的

探讨双侧肉毒毒素 A 治疗联合痉挛髋内收肌后续牵伸对纯遗传性痉挛性截瘫患者步态和反应性横向跨步反应的功能影响。

设计

探索性干预前后研究。

患者

25 例纯遗传性痉挛性截瘫患者。

方法

患者接受双侧髋内收肌肉毒毒素 A 注射治疗,并在 16 周内每天进行自我管理的牵伸运动。在干预前(T0)、6 周(T1)和 16 周(T2)后,评估步态宽度、步态速度以及横向平衡干扰后首次触地脚的腿部角度,以及反应性横向跨步的相应成功率。

结果

与基线相比,T1 和 T2 时步态宽度分别增加了 12.6%和 9.7%,舒适步态速度分别增加了 8.3%和 11.5%。在已知的干扰方向,腿部角度在 T1 时增加了 5.9%,在 T2 时增加了 8.0%,而成功率从基线时的 70%增加到 T1 和 T2 时的 90%。在未知的干扰方向,最大步态速度或横向跨步反应均无变化。

结论

双侧肉毒毒素 A 治疗联合后续牵伸髋内收肌可能改善纯遗传性痉挛性截瘫患者的步态和反应性横向跨步。

相似文献

1
Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia.A型肉毒毒素对遗传性痉挛性截瘫患者髋内收肌的功能影响及其后续拉伸。
J Rehabil Med. 2019 Jun 18;51(6):434-441. doi: 10.2340/16501977-2556.
2
Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia.A型肉毒毒素治疗及随后对痉挛性小腿肌肉进行拉伸的功能效果:一项针对遗传性痉挛性截瘫患者的研究
J Rehabil Med. 2015 Feb;47(2):147-53. doi: 10.2340/16501977-1909.
3
Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.肉毒杆菌毒素注射用于患有遗传性痉挛性截瘫的儿科患者。
J Child Neurol. 2010 Aug;25(8):969-75. doi: 10.1177/0883073809356037. Epub 2010 Apr 20.
4
Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease.联合治疗A型功能性肉毒杆菌毒素(Btx-A)治疗Strumpell-Lorrain病患者。
Curr Pharm Des. 2016;22(6):758-63. doi: 10.2174/1381612822666151204001830.
5
Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.肉毒杆菌毒素注射治疗痉挛性偏瘫型脑瘫患儿腓肠肌和内收肌的功能结局
Eura Medicophys. 2007 Mar;43(1):13-20. Epub 2006 Oct 3.
6
A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot.一项关于A型肉毒杆菌毒素联合非药物治疗痉挛性足的单盲随机试验研究。
J Rehabil Med. 2008 Nov;40(10):870-2. doi: 10.2340/16501977-0251.
7
Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia.移动数字步态分析捕捉肉毒毒素在遗传性痉挛性截瘫中的作用。
Eur J Neurol. 2024 Aug;31(8):e16367. doi: 10.1111/ene.16367. Epub 2024 Jun 10.
8
Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.肉毒杆菌毒素用于遗传性痉挛性截瘫:对运动和非运动表现的影响
Arq Neuropsiquiatr. 2018 Mar;76(3):183-188. doi: 10.1590/0004-282x20180013.
9
Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.随机对照试验研究 A 型肉毒毒素治疗遗传性痉挛性截瘫的疗效—SPASTOX 试验
Mov Disord. 2021 Jul;36(7):1654-1663. doi: 10.1002/mds.28523. Epub 2021 Feb 17.
10
Combined effects of robot‑assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial.机器人辅助步态训练与A型肉毒杆菌毒素联合治疗对慢性脑卒中患者痉挛性马蹄足的影响:一项前瞻性、单盲、随机对照试验
Eur J Phys Rehabil Med. 2016 Dec;52(6):759-766. Epub 2016 Apr 21.

引用本文的文献

1
Outcome measures of instrumented gait analysis in hereditary spastic paraplegia: a systematic review.遗传性痉挛性截瘫中仪器化步态分析的结果测量:一项系统评价
J Neuroeng Rehabil. 2025 Jun 5;22(1):129. doi: 10.1186/s12984-025-01646-4.
2
Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia.移动数字步态分析捕捉肉毒毒素在遗传性痉挛性截瘫中的作用。
Eur J Neurol. 2024 Aug;31(8):e16367. doi: 10.1111/ene.16367. Epub 2024 Jun 10.
3
The use of digital tools in rare neurological diseases towards a new care model: a narrative review.
数字工具在罕见神经系统疾病中的应用:迈向新型护理模式的叙述性综述。
Neurol Sci. 2024 Oct;45(10):4657-4668. doi: 10.1007/s10072-024-07631-4. Epub 2024 Jun 10.
4
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis.A型肉毒毒素在痉挛中的作用:基于文献计量分析的研究趋势。
Toxins (Basel). 2024 Apr 9;16(4):184. doi: 10.3390/toxins16040184.
5
Functional outcomes following surgery for spastic hip adductor muscles in ambulatory and non-ambulatory adults.运动障碍性髋内收肌术后对非卧床和卧床成年患者功能的影响。
J Rehabil Med. 2024 Mar 22;56:jrm18356. doi: 10.2340/jrm.v56.18356.
6
Gait analysis patterns and rehabilitative interventions to improve gait in persons with hereditary spastic paraplegia: a systematic review and meta-analysis.遗传性痉挛性截瘫患者改善步态的步态分析模式及康复干预:一项系统评价与荟萃分析
Front Neurol. 2023 Sep 20;14:1256392. doi: 10.3389/fneur.2023.1256392. eCollection 2023.
7
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.遗传性痉挛性截瘫临床试验的结局指标和生物标志物:范围综述。
Genes (Basel). 2023 Sep 3;14(9):1756. doi: 10.3390/genes14091756.
8
Dysfunctional neuro-muscular mechanisms explain gradual gait changes in prodromal spastic paraplegia.神经肌肉功能障碍机制解释了前驱痉挛性截瘫中步态的逐渐变化。
J Neuroeng Rehabil. 2023 Jul 15;20(1):90. doi: 10.1186/s12984-023-01206-8.
9
Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial.致编辑的信:A型肉毒毒素治疗遗传性痉挛性截瘫的随机试验——SPASTOX试验
Mov Disord. 2021 Jul;36(7):1733. doi: 10.1002/mds.28659.
10
Progression of Functional Gait in Hereditary Spastic Paraplegias.遗传性痉挛性截瘫患者功能性步态的进展
Cerebellum. 2022 Jun;21(3):350-357. doi: 10.1007/s12311-021-01302-2. Epub 2021 Jul 9.